Singapore markets close in 1 hour 14 minutes
Straits Times Index
3,280.09 -7.66 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,637.46 +352.92 (+2.04%) FTSE 100
8,125.89 +47.03 (+0.58%) Bitcoin USD
64,340.77 +425.97 (+0.67%) CMC Crypto 200
1,391.10 -5.43 (-0.39%)
Gilead Sciences, Inc. (GIS.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
As of 09:13AM CEST. Market open.
| Previous close | 61.28 |
| Open | 60.94 |
| Bid | 60.82 x 25500 |
| Ask | 60.99 x 20000 |
| Day's range | 60.93 - 61.12 |
| 52-week range | 60.93 - 80.00 |
| Volume | |
| Avg. volume | 958 |
| Market cap | 76.215B |
| Beta (5Y monthly) | 0.20 |
| PE ratio (TTM) | 14.55 |
| EPS (TTM) | 4.20 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 2.85 (4.65%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
- GuruFocus.com
Gilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
Explore Gilead's latest financial performance and strategic directions, including updates on HIV, oncology, and liver disease segments.
ZacksGilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Barrons.comGilead Beats Earnings Expectations After Rocky Quarter
The biotech reported a loss for the quarter of $1.32 per share, better than the FactSet consensus estimate of a loss of $1.49 per share.
© 2024 Yahoo. All rights reserved.